WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST) Files An 8-K Regulation FD Disclosure
Item 7.01Regulation FD Disclosure.
On January 9, 2019, West Pharmaceutical Services, Inc. (the “Company”) will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California, at 4:30 PM Pacific Time.
A copy of the Company’s presentation materials from the conference will be available through the Investors link at the Company’s website, http://www.westpharma.com, and is also attached hereto as Exhibit 99.1 and incorporated herein by reference.
The information in this report (including Exhibit 99.1) is being furnished to Item 7.01 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject to the liabilities of that section, nor will it be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific referencing in such filing.
Item 9.01Financial Statements and Exhibits.
|
(d) |
Exhibit No. |
Description |
|
99.1 |
West Pharmaceutical Services, Inc. Investor Presentation, dated January 9, 2019. |
WEST PHARMACEUTICAL SERVICES INC Exhibit
EX-99.1 2 jan2019wstpresentation.htm EXHIBIT 99.1 jan2019wstpresentation West Pharmaceutical Services,…
To view the full exhibit click here
About WEST PHARMACEUTICAL SERVICES, INC. (NYSE:WST)
West Pharmaceutical Services, Inc. (West) is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. The Company’s segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems). Its Packaging Systems segment includes primary packaging components and systems for injectable drug delivery, other components used in syringe, intravenous and blood collection systems, and prefillable syringe components. Its Delivery Systems segment includes safety and administration systems, multi-component systems for drug containment and administration and various custom contract-manufacturing solutions.
